|
High Intensity Light Therapy in Alzheimer's Disease Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on High Intensity Light Therapy in Alzheimer's Disease conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. High Intensity Light Therapy in Alzheimer's Disease Clinical research trials and High Intensity Light Therapy in Alzheimer's Disease medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like High Intensity Light Therapy in Alzheimer's Disease. High Intensity Light Therapy in Alzheimer's Disease Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a High Intensity Light Therapy in Alzheimer's Disease clinical trial. Subjects typically recieve the finest healthcare available for their High Intensity Light Therapy in Alzheimer's Disease condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > High Intensity Light Therapy in Alzheimer's Disease  High Intensity Light Therapy in Alzheimer's Disease
High Intensity Light Therapy in Alzheimer's Disease
For Condition: Alzheimer's Disease,Dementia
Status: Recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) , National Institute on Aging (NIA)
Synopsis: The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings and, if so, to determine the best timing for the light therapy. The light levels being used in the study have been shown to improve depression in persons with seasonal affective disorder (SAD) and to relieve sleep problems in persons with jet lag and other body rhythm disturbances. Because persons with AD often will not remain still in front of a fluorescent panel, this project has involved renovations in the study units that provide for even, regulated, high-intensity light in all public areas of the study settings.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Dose Comparison, Crossover Assignment, Efficacy Study
Minimum Age/Maximum Age: 60 Years/
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Diagnosis of dementia - Residence on study units Exclusion criteria: - Bipolar disorder - Severe retinal (eye) disease
Total Enrollment: 180
Location and Contact Information:
Overall Study Official:
PhilipSloane, Principal Investigator,
John Umstead Hospital *Recruiting*
Butner, North Carolina, 27514
United States
Recruiting C. Mitchell 919-966-6074
Additional Information:
Study ID Numbers: 1 R01 AT00212-01A1; SloaneP
Study Start Date: March 2003
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00065689
Other Dementia Studies:
1. Alzheimer's Disease and Aging: Therapeutic potential of estrogen
2. Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
3. PET Scan of Brain Metabolism in Relation to Age and Disease
4. Prevention of cognitive decline in Alzheimer's disease by ingested interferon alpha
5. Study of an Investigational Drug for the treatment of Alzheimer's Disease
Related Studies:
Other Dementia Clinical Trials
Other North Carolina Clinical Trials
Other Butner Clinical Trials
High Intensity Light Therapy in Alzheimer's Disease
|
|
|
|
|
|
|
|
